Literature DB >> 9472572

Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser.

P G Harries1, M J Brockbank, P G Shakespeare, J A Carruth.   

Abstract

Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome, Osler's disease) is an inherited abnormality of the vasculature characterized by abnormal subepithelial vessels. Treatment has included repeated intranasal cautery, intra-arterial embolization and arterial ligation. Historically, the operation of septodermoplasty and the use of systemic/topical oestrogens have been the most effective and lasting treatments, but over time the telangiectasias recur. There is increasing interest in the use of a variety of lasers for intranasal photocoagulation. A report of nine patients suffering from hereditary haemorrhagic telangiectasia who have undergone laser treatment with the Chromos pulsed dye laser is presented. This laser produces light energy at a wavelength of 585 nm and causes localized thermal damage to the blood vessel wall. Initially, no patient saw an improvement in their symptoms, but following an average of approximately three courses of treatment, all have reported a measurable reduction in the number of epistaxes suffered. Although no treatment completely resolves the epistaxis associated with this condition, we have found the pulsed dye laser to be effective at treating telangiectasias within the anterior nasal cavity.

Entities:  

Mesh:

Year:  1997        PMID: 9472572     DOI: 10.1017/s0022215100139283

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  7 in total

1.  Diode laser coagulation for the treatment of epistaxis in a Scottish fold cat.

Authors:  Takuma Aoki; Hiroo Madarame; Keisuke Sugimoto; Hiroshi Sunahara; Yoko Fujii; Eiichi Kanai; Tetsuro Ito
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

Review 2.  Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.

Authors:  Arash Abiri; Khodayar Goshtasbi; Marlon Maducdoc; Ronald Sahyouni; Marilene B Wang; Edward C Kuan
Journal:  Lasers Surg Med       Date:  2019-08-22       Impact factor: 4.025

3.  Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic.

Authors:  Yuchen Jiang; Simon C Dennis; Mark P Brewin
Journal:  Lasers Med Sci       Date:  2022-05-30       Impact factor: 2.555

4.  Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm).

Authors:  A Werner; W Bäumler; S Zietz; T Kühnel; U Hohenleutner; M Landthaler
Journal:  Lasers Med Sci       Date:  2007-11-13       Impact factor: 3.161

5.  Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia.

Authors:  M L Fiorella; L Lillo; R Fiorella
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-06       Impact factor: 2.124

6.  Epistaxis Runs in the Family.

Authors:  Abheek Sil; Dibyendu Bikash Bhanja; Sayantani Chakraborty
Journal:  Oman Med J       Date:  2021-03-31

Review 7.  Light-Based Devices for the Treatment of Facial Erythema and Telangiectasia.

Authors:  Vani Yepuri; Anant D Patil; Klaus Fritz; Carmen Salavastru; George Kroumpouzos; Steven Paul Nisticò; Domenico Piccolo; Ahmed Sadek; Ashraf Badawi; Martin Kassir; Michael H Gold; Stephan Große-Büning; Stephan Grabbe; Mohamad Goldust
Journal:  Dermatol Ther (Heidelb)       Date:  2021-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.